Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro

Haematologica

Volumn 85, Issue 8, 2000, Pages 806-813

  Vilpo, J ^a   Koski, T ^a   Vilpo, L ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Anticancer drugs; Calcium channel blockers; Chronic lymphocytic leukemia; Cytotoxicity

Indexed keywords

2 CHLORODEOXYADENOSINE; ANNEXIN; ANTINEOPLASTIC AGENT; CALCIUM ANTAGONIST; CHLORAMBUCIL; CISPLATIN; CYCLOSPORIN; DOXORUBICIN; FLUDARABINE; GLYCOPROTEIN P; NIFEDIPINE; PREDNISOLONE; VERAPAMIL; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LEUKEMIA; CELL DEATH; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; B-LYMPHOCYTES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CHLORAMBUCIL; CISPLATIN; CLADRIBINE; COMPARATIVE STUDY; CYCLOSPORINE; DNA FRAGMENTATION; DOXORUBICIN; DRUG SYNERGISM; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGE; NIFEDIPINE; P-GLYCOPROTEIN; PREDNISOLONE; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; VERAPAMIL; VIDARABINE; VINCRISTINE;

EID: 0033834811     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Multidrug resistance in leukaemia
2. Mechanisms of drug resistance in hematologic malignancies
3. Pharmacologic approaches to reversing multidrug resistance
4. Expression of mdr1 and mrp in the normal B-cell homologue of B-cell chronic lymphocytic leukaemia
5. A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells
6. Spectral morphometric characterization of B-CLL cells versus normal small lymphocytes
7. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type
8. Quantification of P-glycoprotein in chronic lymphocytic leukemia by flow cytometry
9. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia
10. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias
11. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders
12. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
13. Prognostic significance of bone-marrow patterns in chronic lymphocytic leukaemia
14. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders
15. Non-specific binding compromises the purification yields of leukemic B-cells in chronic lymphocytic leukemia: Prevention by collagen coating
16. Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease
17. Selective toxicity of vincristine against chronic lymphocytic leukaemia in vitro. The Tampere CLL Group
18. Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-β-D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia
19. Cadmium induces apoptosis in a human T cell line
20. 2-Methoxyacetic acid (MAA)-induced spermatocyte apoptosis in human and rat testes: An in vitro comparison
21. 2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells
22. Prevention of apoptosis reperfusion renal injury by calcium channel blockers
23. NGF-induced cytotoxicity in PC12 cells in a hypoglycemic environment
24. Hyperthermia and verapamil inhibit the growth of human colon cancerxenografts in vivo through apoptosis
25. Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia
26. The study of innate resistance of human hepatocellular carcinoma Bel7402 cell line
27. Calcium - A life and death signal
28. The action of calcium channel blockers on recombinant L-type calcium channel α1-subunits
29. Calcium-antagonist drugs